SPHSSophiris Bio Inc.

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$34.00
Vol1,000.00

About

Sophiris Bio is a biotech company that develops a treatment for the symptoms of benign prostatic hyperplasia. Their product includes topsalysin for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia and for the treatment of low- to intermediate-risk prostate cancer.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Sophiris Bio Inc?
What is the 52-week high for Sophiris Bio Inc?
What was Sophiris Bio Inc stock price yesterday?
What is the 50-day moving average of Sophiris Bio Inc?

Latest SPHS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.